Oscar Health, Inc. (OSCR) Key Statistics & Metrics

Oscar Health, Inc. (OSCR) has an ST Score of 71.3 (B+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate OSCR a Hold, with a price target of $37.43 (+11.2% vs the current price). Our ST Score grades it B+ (71.3/100). The ST Score is a data-driven signal, not a recommendation.

Valuation C-, Profitability A+, Financial Strength B, Momentum B-, Growth A, Forecast B+, Sentiment A+.

Oscar Health, Inc. (OSCR) earns a valuation grade of C-, measured against Medical - Healthcare Plans peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Oscar Health, Inc. (OSCR) earns a growth grade of A, measured against Medical - Healthcare Plans peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Oscar Health, Inc. (OSCR) earns a profitability grade of A+, measured against Medical - Healthcare Plans peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Oscar Health, Inc. (OSCR) earns a financial strength grade of B, measured against Medical - Healthcare Plans peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Oscar Health, Inc. (OSCR) is $37.43 from 13 analysts, which is +11.2% versus the recent price of $33.66.

Oscar Health, Inc. (OSCR) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.